Login / Signup

Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trial.

Damian MeyersburgMagdalena HoellwerthMatthias BrandlmaierAllesandra HandisuryaAndreas KaiserChristine ProdingerJohann W Bauer
Published in: The British journal of dermatology (2024)
Topical permethrin demonstrated a lack of efficacy in the majority of scabies cases, whereas BB demonstrated an excellent cure rate and reasonable tolerability. Considering the reduced sensitivity of scabies mites to permethrin 5%, our results suggest that BB is an appropriate first-line therapy in the treatment of scabies.
Keyphrases
  • randomized controlled trial
  • growth factor
  • systematic review
  • bone marrow
  • combination therapy
  • open label
  • wound healing
  • replacement therapy